Scott K Sherman
Overview
Explore the profile of Scott K Sherman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
501
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Skalitzky M, Zhou P, Goffredo P, Guyton K, Sherman S, Gribovskaja-Rupp I, et al.
Surgery
. 2023 Mar;
173(5):1137-1143.
PMID: 36872174
Background: The incidence of colorectal cancer in patients <50 years has rapidly risen recently. Understanding the presenting symptoms may facilitate earlier diagnosis. We aimed to delineate patient characteristics, symptomatology, and...
12.
Sharma R, Zafar H, Sherman S, Niyazi F
ACG Case Rep J
. 2023 Jan;
9(12):e00910.
PMID: 36600798
A 56-year-old man presented with recurrent gastrointestinal obstruction. Computed tomography showed fluid-filled, distended stomach, small intestine, and large intestine. Extensive workup including esophagogastroduodenoscopy, colonoscopy, magnetic resonance enterography, push enteroscopy, and...
13.
Suraju M, Snow A, Nayyar A, Chang J, Sherman S, Hoshi H, et al.
J Surg Res
. 2022 Nov;
283:479-484.
PMID: 36436283
Introduction: Peritoneal metastases (PMs) following resection of pancreatic intraductal papillary mucinous neoplasms (IPMNs) are rare. Consequently, prevalence, risk factors, and prognosis are not well known. We reviewed our institution's experience...
14.
Ziogas I, Tasoudis P, Borbon L, Sherman S, Breheny P, Chandrasekharan C, et al.
Ann Surg Oncol
. 2022 Oct;
30(1):148-160.
PMID: 36227392
Background: Grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are rare, aggressive tumors with poor prognosis. The World Health Organization 2017 and 2019 classifications further subdivided G3 NENs into G3...
15.
Borbon L, Tran C, Sherman S, Ear P, Chandrasekharan C, Bellizzi A, et al.
Ann Surg Oncol
. 2022 Jul;
29(11):6936-6946.
PMID: 35802214
Background: Grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are aggressive tumors with poor survival outcomes for which medical management is generally recommended. This study sought to evaluate outcomes of...
16.
Dahdaleh F, Sherman S, Witmer H, Dhiman A, Rajeev R, Poli E, et al.
Am J Surg
. 2022 Jan;
224(1 Pt B):459-464.
PMID: 35090686
Background: Relapse of early-stage colon cancer (CC) after curative-intent resection occurs. We hypothesized that known risk factors for peritoneal metastases (PM) can define a high-risk state (HRS) that predicts recurrence...
17.
Chang A, Sherman S, Howe J, Sahai V
Annu Rev Med
. 2021 Oct;
73:213-229.
PMID: 34669433
Pancreatic neuroendocrine tumors (PNETs) are a heterogeneous and orphan group of neoplasms that vary in their histology, clinical features, prognosis, and management. The treatment of PNETs is highly dependent on...
18.
ASO Author Reflections: Endoscopic Management is Reasonable for <2 cm Duodenal Neuroendocrine Tumors
Tran C, Sherman S, Howe J
Ann Surg Oncol
. 2021 Oct;
29(1):85-86.
PMID: 34608558
Optimal management of duodenal neuroendocrine tumors (DNETs) has not been well-defined, especially for DNETs 1-2 cm in size. Recent studies comparing endoscopic mucosal resection (EMR) and surgical resection demonstrate EMR...
19.
Tran C, Sherman S, Suraju M, Nayyar A, Gerke H, El Abiad R, et al.
Ann Surg Oncol
. 2021 Sep;
29(1):75-84.
PMID: 34515889
Background: Management of duodenal neuroendocrine tumors (DNETs) is not standardized, with smaller lesions (< 1-2 cm) generally treated by endoscopic mucosal resection (EMR) and larger DNETs by surgical resection (SR)....
20.
van der Heide D, Turaga K, Chan C, Sherman S
J Surg Res
. 2021 May;
266:104-112.
PMID: 33989889
Background: Young adults with metastatic colorectal cancer (mCRC) may have higher rates of deficient mismatch repair (dMMR) than older patients. This study sought to assess patterns of MMR-testing and survival...